Ovid Therapeutics Inc (NASDAQ:OVID)
| 5.34 Delayed Data As of Oct 23 |  -0.03 / -0.56%Today’s Change | 1.80 Today|||52-Week Range 9.40 | +28.67% Year-to-Date |
Latest OVID News | Press Releases
No recent news for Ovid Therapeutics Inc.
Today’s Trading
| Previous close | 5.37 |
| Today’s open | 5.37 |
| Day’s range | 5.25 - 5.43 |
| Volume | 473,409 |
| Average volume (3 months) | 1,295,344 |
| Market cap | $338.2M |
Data as of 4:00pm ET, 10/23/2020
Growth & Valuation
| Earnings growth (last year) | +26.94% |
| Earnings growth (this year) | +1.12% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.17 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IMUXImmunic Inc | +0.02 | +0.12% |
| BDSIBioDelivery Sciences... | +0.15 | +4.62% |
| CPRXCatalyst Pharmaceuti... | +0.01 | +0.31% |
| CNCEConcert Pharmaceutic... | -0.17 | -1.41% |
Data as of 4:00pm ET, 10/23/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$60.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
